Please Note:

The Open Access Repository has moved to a new authentication system as of the 1st of November.

Account holders will now be able to login using their University of Tasmania credentials.
If you have trouble logging in please email us on E.Prints@utas.edu.au so we can assist you.

Public users can still access the records in this repository as normal

Open Access Repository

Effect of celecoxib on cyclooxygenase-2 expression and possible variants in a patient with Barrett's esophagus

Downloads

Downloads per month over past year

Jacobson, GA and Narkowicz, CK and Lord, RJ and Howard, BJ and Chung, S (2007) Effect of celecoxib on cyclooxygenase-2 expression and possible variants in a patient with Barrett's esophagus. Diseases of the Esophagus, 20 (3). pp. 265-268. ISSN 1120-8694

[img] PDF
4361.pdf | Request a copy
Full text restricted

Abstract

SUMMARY. Cyclooxygenase-2 (COX-2) expression is increased in metaplastic and dysplastic Barrett's esophageal epithelium and it is thought that selective COX-2 inhibitors could offer hope as chemoprevention therapy. The aim of the study was to investigate the in vivo effect of celecoxib on COX-2 expression in patients with Barrett's esophagus and no recent history of non-steroidal anti-inflammatory drug use. Endoscopic mucosal biopsy specimens were collected at baseline and after 28 days of therapy in a patient treated with celecoxib 200 mg twice daily. Samples were analyzed for COX-2 expression by immunoblot analysis with chemiluminescence detection. COX-2 expression was found to decline 20% and 44% at two different biopsy sites compared to the baseline sample. Longer exposures revealed a number of previously unidentified proteins above and below the 67 kDa COX-2 protein including 38 kDa and 45 kDa proteins which were present only at study completion consistent with up-regulation after celecoxib therapy. Further investigations of the 38 kDa and 45 kDa proteins were undertaken using two-dimensional polyacrylamide gel electrophoresis (2D-PAGE) with immunoblot and MALDI-TOF (matrix assisted laser desorption ionization – time of flight) analysis but no matches were found and results were inconclusive. Unmatched masses from MALDI-TOF peptide mass fingerprinting were compared with human COX-2 (67 kDa) and COX-2b (39 kDa) using unspecific cleavage. Peptide sequence homology with COX-2 and COX-2b was found for a length of 19 amino acids. Based on immunodetection, molecular weight and equivical MALDI-TOF results, one of these up-regulated proteins may be COX-2b.

Item Type: Article
Keywords: Barrett's esophagus • celecoxib • COX-2 • cyclooxygenase-2
Journal or Publication Title: Diseases of the Esophagus
Publisher: Blackwell Publishing
Page Range: pp. 265-268
ISSN: 1120-8694
Identification Number - DOI: 10.1111/j.1442-2050.2007.00684.x
Additional Information:

The definitive version is available at www.blackwell-synergy.com

Date Deposited: 07 Apr 2008 14:35
Last Modified: 18 Nov 2014 03:35
Item Statistics: View statistics for this item

Actions (login required)

Item Control Page Item Control Page
TOP